Choline Kinase α Inhibitors MN58b and RSM932A Enhances the Antitumor Response to Cisplatin in Lung Tumor Cells

Lung cancer is one of the main causes of death in developed countries, and non-small cell lung cancer (NSCLC) is the most frequent type (80% of patients). In advanced NSCLC, platinum-based chemotherapy is the frontline palliative treatment, but less than 5% of patients achieve prolonged survival. Im...

Descripción completa

Detalles Bibliográficos
Autores principales: Lacal, Juan Carlos, Perona, Rosario, de Castro, Javier, Cebrián, Arancha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230389/
https://www.ncbi.nlm.nih.gov/pubmed/35745716
http://dx.doi.org/10.3390/pharmaceutics14061143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9230389/
https://www.ncbi.nlm.nih.gov/pubmed/35745716
http://dx.doi.org/10.3390/pharmaceutics14061143

Ejemplares similares